Healthcare
ABBV vs JNJ: pairs trade
AbbVie (ABBV) is a biopharmaceutical company. Johnson & Johnson (JNJ) is a pharmaceutical and medical-technology company. Large pharmaceutical companies tend to move together because they share the same drivers: drug pricing policy, regulation and investor appetite for defensive stocks. When the gap between them stretches unusually far, the model measures how far, and how long such gaps have typically taken to close.
How far apart, versus normal
Where the pair stands tonight — and the exact levels the model uses — is in the full report.
Qualification
A pair has to re-qualify on every nightly scan (stationarity and half-life tests); if it fails, it is benched and publishes nothing that night. Repeated stress at the safety-stop distance suspends it. Why pairs get benched →
Published signals
Every time the full report flagged ABBV / JNJ, listed 30 days after publication.
Nothing has cleared the 30-day delay yet.
How each signal resolved is published on the track record once it meets our publication bar.
Related pairs
New to this? What is pairs trading · Half-life explained · All explainers
See them the evening they are published
This page runs 30 days behind. The full report carries every opportunity the evening the model flags it.
Start a 7-day free trial →Available to US residents only — US-listed equities.